Captrust Financial Advisors Axsome Therapeutics, Inc. Transaction History
Captrust Financial Advisors
- $33 Billion
- Q3 2024
A detailed history of Captrust Financial Advisors transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 5,722 shares of AXSM stock, worth $594,458. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,722Holding current value
$594,458% of portfolio
0.0%Shares
12 transactions
Others Institutions Holding AXSM
# of Institutions
327Shares Held
37.7MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$435 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$415 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$343 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$245 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$109 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.45B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...